Assessment of the immunogenicity and safety of marketed vaccines for COVID-19 after regular schedule and adapted vaccine schedules: BNT162b2 (Comirnaty®; Pfizer-BioNTech), mRNA-1273 Vaccine (COVID-19 Vaccine Moderna®; Moderna) and ChAdOx1 nCoV-19 (COVID-1
COVID19 - Trivoice PLUS - Astra-Zeneca derde dosis, Vaccinatie tegen covid-19 bij kankerpatiënten: booster prik BNT161b2 vaccin na volledige vaccinatie met ChAdOx1-S vaccin (Tri-VOICE plus).
COVID19 - TriVoice - derde dosis, Vaccinatie tegen covid-19 bij kankerpatiënten onder actieve behandeling (België, B-VOICE)
COVID19 - ONCO-VAC, Vaccinatie tegen covid-19 bij kankerpatiënten onder actieve behandeling (België, B-VOICE)
Hoe meer je zegt hoe en waarom verspreiding van COVID-19 te vermijden, hoe meer ik vind dat ik me de moeite kan besparen. Naleving van maatregelen tegen COVID-19 verbeteren door neveneffecten van oproepen tot voorzorgsgedrag te vermijden.
Recovery from COVID-19: a sprint or marathon? 24-week follow-up data of online long COVID-19 peer support groups
Hypertension and related diseases in the era of COVID-19: a report from the Japanese Society of Hypertension Task Force on COVID-19
Recovery from COVID-19: a sprint or marathon? 6-month follow-up data from online long COVID-19 support group members
Replication Data for: "Covid-19 vs. Ebola: impact on households and small businesses in North Kivu, Democratic Republic of Congo" Forthcoming in World Development
Dataset for Intervention strategies against COVID-19 and their estimated impact on Swedish healthcare capacity